Gentex price target raised to $26 from $24 at UBS

UBS raised the firm’s price target on Gentex (GNTX) to $26 from $24 and keeps a Neutral rating on the shares following the Q1 report. The firm sees “some irons in the fire” for the company’s growth picking up in 2027 and 2028. It views Gentex as an “interesting emerging growth opportunity.”